FREEDOM COVID: Full-Dose Anticoagulation Cut Mortality

In an in-hospital anticoagulation trial, the primary COVID endpoint was missed, but a survival benefit was observed.
MDedge News

source https://www.medscape.com/viewarticle/989565?src=rss

Comments

Popular posts from this blog

Student Nurses Who Refuse Vaccination Struggle to Complete Degrees

The Clinical Characteristics of Fractures in Pediatric Patients Exposed to Proton Pump Inhibitors